FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168023876> ?p ?o ?g. }

• W2168023876 endingPage "15" @default.
• W2168023876 startingPage "15" @default.
• W2168023876 abstract "New oral anticoagulants (NOAC) are approved for several indications for prophylaxis and treatment of venous thromboembolism and for prevention of embolism in atrial fibrillation at fixed daily doses without need of laboratory guided dose adjustment. Due to their low molecular weight of about 500 to 600 Dalton and their hydrophilicity free anticoagulant is excreted immediately through glomerular filtration into the urine. Impairment of renal function may increase the plasma concentration of the anticoagulants and lowered creatinine clearance is a declared contraindication. In contrast to the initial aim of development the anticoagulant effect is required to be determined in special clinical situations. Several specific and non-specific assays using plasma samples are currently undergoing standardization. As all NOACs are excreted into the urine, specific assays were developed for this matrix to determine them quantitatively of qualitatively. Urine samples can be easily and repetitively obtained avoiding problems and risks associated with blood sampling. The qualitative assay can be performed as a point of care test (POC) also by the patient by judging the different colours for the absence or presence of the drugs with the naked eye. The test is rapid (results available within 15 min), sensitive, specific and accurate and does not require a purified NOAC as control. The tests may be a tool for clinicians who need to know for treatment decisions if a NOAC is on board or not. As the tests are specific for oral direct thrombin inhibitors and for oral direct factor Xa inhibitors, the indication does not interfere with other qualitative POC test in development using clotting systems. The test may be indicated for patients at acute hospitalization, before surgery or central nervous system puncture anaesthesia, if fibrinolytic therapy is indicated, acute deterioration of renal function, and for control of adherence to therapy." @default.
• W2168023876 created "2016-06-24" @default.
• W2168023876 creator A5014209447 @default.
• W2168023876 creator A5022747322 @default.
• W2168023876 creator A5035801023 @default.
• W2168023876 creator A5067571033 @default.
• W2168023876 creator A5074142514 @default.
• W2168023876 date "2013-01-01" @default.
• W2168023876 modified "2023-10-16" @default.
• W2168023876 title "Concept of a point of care test to detect new oral anticoagulants in urine samples" @default.
• W2168023876 cites W1485772655 @default.
• W2168023876 cites W1981337122 @default.
• W2168023876 cites W1990877161 @default.
• W2168023876 cites W2008804852 @default.
• W2168023876 cites W2011936209 @default.
• W2168023876 cites W2021740863 @default.
• W2168023876 cites W2024660690 @default.
• W2168023876 cites W2037424563 @default.
• W2168023876 cites W2047926237 @default.
• W2168023876 cites W2068476516 @default.
• W2168023876 cites W2085700828 @default.
• W2168023876 cites W2140436541 @default.
• W2168023876 cites W2148757932 @default.
• W2168023876 cites W2161098783 @default.
• W2168023876 cites W2162149991 @default.
• W2168023876 cites W3016782834 @default.
• W2168023876 cites W4231613903 @default.
• W2168023876 doi "https://doi.org/10.1186/1477-9560-11-15" @default.
• W2168023876 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3766639" @default.
• W2168023876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23915217" @default.
• W2168023876 hasPublicationYear "2013" @default.
• W2168023876 type Work @default.
• W2168023876 sameAs 2168023876 @default.
• W2168023876 citedByCount "22" @default.
• W2168023876 countsByYear W21680238762014 @default.
• W2168023876 countsByYear W21680238762015 @default.
• W2168023876 countsByYear W21680238762016 @default.
• W2168023876 countsByYear W21680238762017 @default.
• W2168023876 countsByYear W21680238762018 @default.
• W2168023876 countsByYear W21680238762019 @default.
• W2168023876 countsByYear W21680238762021 @default.
• W2168023876 countsByYear W21680238762022 @default.
• W2168023876 countsByYear W21680238762023 @default.
• W2168023876 crossrefType "journal-article" @default.
• W2168023876 hasAuthorship W2168023876A5014209447 @default.
• W2168023876 hasAuthorship W2168023876A5022747322 @default.
• W2168023876 hasAuthorship W2168023876A5035801023 @default.
• W2168023876 hasAuthorship W2168023876A5067571033 @default.
• W2168023876 hasAuthorship W2168023876A5074142514 @default.
• W2168023876 hasBestOaLocation W21680238761 @default.
• W2168023876 hasConcept C126322002 @default.
• W2168023876 hasConcept C142724271 @default.
• W2168023876 hasConcept C159641895 @default.
• W2168023876 hasConcept C177713679 @default.
• W2168023876 hasConcept C204787440 @default.
• W2168023876 hasConcept C2776301958 @default.
• W2168023876 hasConcept C2776494729 @default.
• W2168023876 hasConcept C2777292125 @default.
• W2168023876 hasConcept C2778205648 @default.
• W2168023876 hasConcept C2778661090 @default.
• W2168023876 hasConcept C2778810321 @default.
• W2168023876 hasConcept C2779161974 @default.
• W2168023876 hasConcept C2780026642 @default.
• W2168023876 hasConcept C2780638905 @default.
• W2168023876 hasConcept C42219234 @default.
• W2168023876 hasConcept C51915194 @default.
• W2168023876 hasConcept C57002609 @default.
• W2168023876 hasConcept C64841741 @default.
• W2168023876 hasConcept C71924100 @default.
• W2168023876 hasConcept C74414138 @default.
• W2168023876 hasConcept C89560881 @default.
• W2168023876 hasConceptScore W2168023876C126322002 @default.
• W2168023876 hasConceptScore W2168023876C142724271 @default.
• W2168023876 hasConceptScore W2168023876C159641895 @default.
• W2168023876 hasConceptScore W2168023876C177713679 @default.
• W2168023876 hasConceptScore W2168023876C204787440 @default.
• W2168023876 hasConceptScore W2168023876C2776301958 @default.
• W2168023876 hasConceptScore W2168023876C2776494729 @default.
• W2168023876 hasConceptScore W2168023876C2777292125 @default.
• W2168023876 hasConceptScore W2168023876C2778205648 @default.
• W2168023876 hasConceptScore W2168023876C2778661090 @default.
• W2168023876 hasConceptScore W2168023876C2778810321 @default.
• W2168023876 hasConceptScore W2168023876C2779161974 @default.
• W2168023876 hasConceptScore W2168023876C2780026642 @default.
• W2168023876 hasConceptScore W2168023876C2780638905 @default.
• W2168023876 hasConceptScore W2168023876C42219234 @default.
• W2168023876 hasConceptScore W2168023876C51915194 @default.
• W2168023876 hasConceptScore W2168023876C57002609 @default.
• W2168023876 hasConceptScore W2168023876C64841741 @default.
• W2168023876 hasConceptScore W2168023876C71924100 @default.
• W2168023876 hasConceptScore W2168023876C74414138 @default.
• W2168023876 hasConceptScore W2168023876C89560881 @default.
• W2168023876 hasIssue "1" @default.
• W2168023876 hasLocation W21680238761 @default.
• W2168023876 hasLocation W21680238762 @default.
• W2168023876 hasLocation W21680238763 @default.
• W2168023876 hasLocation W21680238764 @default.
• W2168023876 hasOpenAccess W2168023876 @default.

• next